Dr François-Louis CAMPANA

Biographie CV

François-Louis CAMPANA (né le 29/08/1954  à Paris) est un oncologue radiothérapeute français.



Baccalauréat section c mention AB 1972

Etudes de médecine Faculté Saint Antoine



1) Lauréat de la faculté de Médecine de Paris.


3) Médecin COMPETANT qualifié en CANCEROLOGIE 7/1988

4) Chef de service des consultations médico chirurgicales 2005/2009

5) Médecin expert en cancérologie 1/2008

6) Chef de service du plateau technique de radiothérapie site ULM 2009/2015

7) Médecin Coordinateur unité de surveillance des cancers du sein 01/2016

8) Membre de l’ESTRO



  1. Whole breast radiotherapy in the lateral isocentric lateral decubitus position: Long-term efficacy and toxicity results.

Bronsart E, Dureau S, Xu HP, Bazire L, Chilles A, Costa E, Logerot C, Falcou MC, Campana F, Berger F, Fourquet A, Kirova YM.

Radiother Oncol. 2017 Aug;124(2):214-219. doi: 10.1016/j.radonc.2017.07.001. Epub 2017 Jul 19.


  1. Combination of radiotherapy and double blockade HER2 with pertuzumab and trastuzumab for HER2-positive metastatic or locally recurrent unresectable and/or metastatic breast cancer: Assessment of early toxicity.

Ajgal Z, de Percin S, Diéras V, Pierga JY, Campana F, Fourquet A, Kirova YM.


Cancer Radiother. 2017 Mar 24. pii: S1278-3218(17)30044-6. 10.1016/j.canrad.2016.10.002.


  1. Medico-economic impact of MSKCC non-sentinel node prediction nomogram for ER-positive HER2-negative breast cancers


Bonsang-Kitzis H, Mouttet-Boizat D, Guillot E, Feron JG, Fourchotte V, Alran S, Pierga JY, Cottu P, Lerebours F, Stevens D, Vincent-Salomon A, Sigal-Zafrani B, Campana F, Rouzier R, Reyal F.


Plos.One.2017 Feb 27;12(2):e0169962


  1. Postmastectomy Electron Beam Radiation Therapy (PMERT): Efficacy and Toxicity.


Grellier Adedjouma N, Chevrier M, Fournier-Bidoz N, Campana F, Berger F, Fourquet A, Peurien D, Lefeuvre D, Kirova YM.


Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):E40. doi:        10.1016/j.ijrobp.2016.06.693. No abstract available.


  1. Helical tomotherapy and volumetric modulated arc therapy: New therapeutic arms in the breast cancer radiotherapy.


Lauche O, Kirova YM, Fenoglietto P, Costa E, Lemanski C, Bourgier C, Riou O, Tiberi D, Campana F, Fourquet A, Azria D.


World J Radiol. 2016 Aug 28;8(8):735-42. doi: 10.4329/wjr.v8.i8.735


  1. Normofractionated breast irradiation in breast cancer. Indications and benefits


Fourquet A, Krhili SL, Campana F, Chilles A, Kirova YM.


Cancer Radiother. 2016 Oct;20(6-7):564-6. doi: 10.1016/j.canrad.2016.07.093. Epub 2016 Aug 31. French.


  1. REBECA: a phase I study of bevacizumab and whole-brain radiation therapy for the treatment of brain metastasis from solid tumours.

Lévy C, Allouache D, Lacroix J, Dugué AE, Supiot S, Campone M, Mahe M, Kichou S, Leheurteur M, Hanzen C, Dieras V, Kirova Y, Campana F, Le Rhun E, Gras L, Bachelot T, Sunyach MP, Hrab I, Geffrelot J, Gunzer K, Constans JM, Grellard JM, Clarisse B, Paoletti X.

Ann Oncol. 2015 Nov;26(11):2359..


  1. Late toxicities and outcomes of adjuvant radiotherapy combined with concurrent bevacizumab in patients with triple-negative non-metastatic breast cancer.

Pernin V, Belin L, Cottu P, Bontemps P, Lemanski C, De La Lande B, Baumann P, Missohou F, Levy C, Peignaux K, Reynaud-Bougnoux A, Denis F, Gobillion A, Bollet M, Vago NA, Dendale R, Campana F, Fourquet A, Kirova YM.

Br J Radiol. 2015 Apr;88(1048):20140800. doi: 10.1259/bjr.20140800. Epub 2015 Feb 3.


  1. Concurrent administration of trastuzumab with locoregional breast radiotherapy: long-term results of a prospective study.


Jacob J, Belin L, Pierga JY, Gobillion A, Vincent-Salomon A, Dendale R, Beuzeboc P, Campana F, Fourquet A, Kirova YM.

Breast Cancer Res Treat. 2014 Nov;148(2):345-53. doi: 10.1007/s10549-014-3166-5. Epub 2014 Oct 16.


  1. Radiotherapy for breast cancer and erythrokeratodermia variabilis.

Pernin V, Kirova Y, Campana F.

Cancer Radiother. 2014 Dec;18(8):767-9. doi: 10.1016/j.canrad.2014.06.026. Epub 2014 Oct 8.


  1. Radiotherapy associated with concurrent bevacizumab in patients with non-metastatic breast cancer.

Pernin V, Belin L, Cottu P, Bontemps P, Lemanski C, De La Lande B, Baumann P, Missohou F, Levy C, Peignaux K, Bougnoux P, Denis F, Bollet M, Dendale R, Vago NA, Campana F, Fourquet A, Kirova YM.

Breast. 2014 Dec;23(6):816-20. doi: 10.1016/j.breast.2014.08.015. Epub 2014 Sep 26.


  1. Whole breast radiotherapy in the lateral decubitus position: a dosimetric and clinical solution to decrease the doses to the organs at risk (OAR).

Kirova YM, Hijal T, Campana F, Fournier-Bidoz N, Stilhart A, Dendale R, Fourquet A.

Radiother Oncol. 2014 Mar;110(3):477-81. doi: 10.1016/j.radonc.2013.10.038. Epub 2013 Dec 13.



  1. Preliminary results of whole breast helical tomotherapy with simultaneous integrated boost in the adjuvant treatment of breast cancerLiem X, Chira C, Fourquet A, Campana F, Peurien D, Fournier-Bidoz N, Kirova YM. Cancer Radiother. 2013 Dec 5.
  2. Helical tomotherapy for inoperable breast cancer: a new promising tool.

Chira C, Kirova YM, Liem X, Campana F, Peurien D, Amessis M, Fournier-Bidoz N, Pierga JY, Dendale R, Bey P, Fourquet A.

Biomed Res Int. 2013;2013:264306.


  1. Prospective monocentric study of the toxicity and the efficacy of concurrent trastuzumab and radiotherapy].

Jacob J, Belin L, Gobillion A, Daveau-Bergerault C, Dendale R, Beuzeboc P, Campana F, Bollet MA, Fourquet A, Kirova YM.

Cancer Radiother. 2013 Jun;17(3):183-90. doi: 10.1016/j.canrad.2012.12.006. 4.


  1. Visualisation of the left anterior descending coronary artery on CT images used for breast radiotherapy planning.

Vennarini S, Fournier-Bidoz N, Aristei C, de Almeida CE, Servois V, Campana F, Mosseri V, Fourquet A, Kirova YM.

Br J Radiol. 2013 May;86(1025):20120643. doi: 10.1259/bjr.20120643


  1. Concurrent use of aromatase inhibitors and hypofractionated radiation therapy.

Chargari C, Castro-Pena P, Toledano I, Bollet MA, Savignoni A, Cottu P, Laki F, Campana F, De Cremoux P, Fourquet A, Kirova YM.

World J Radiol. 2012 Jul 28;4(7):318-23.


  1. Prospective and Comparative Evaluation of the Toxicity of Adjuvant Concurrent Chemoradiotherapy After Neoadjuvant Chemotherapy for Breast Cancer.

Marchand V, Angelergues A, Gobaux V, Hajage D, Kirova YM, Campana F, Dendale R, Reyal F, Pierga JY, Fourquet A, Bollet MA.

Am J Clin Oncol. 2012 Jun 14. [Epub ahead of print]



[PubMed – as supplied by publisher]


  1. Implant breast reconstruction followed by radiotherapy: can helical tomotherapy become a standard irradiation treatment?

Massabeau C, Fournier-Bidoz N, Wakil G, Castro Pena P, Viard R, Zefkili S, Reyal F, Campana F, Fourquet A, Kirova YM.

Med Dosim. 2012 Winter;37(4):425-31. doi: 10.1016/j.meddos.2012.03.006. Epub 2012 Apr 24.


  1. [Breast conserving surgery in locoregional treatment of breast carcinoma after Hodgkin lymphoma].

Haberer S, Belin L, Le Scodan R, Kirova YM, Savignoni A, Stevens D, Moisson P, Decaudin D, Pierga JY, Reyal F, Campana F, Fourquet A, Bollet MA.

Cancer Radiother. 2012 Apr;16(2):128-35. doi: 10.1016/j.canrad.2011.10.013. Epub 2012 Feb 15. French.